Abiopharma

New Form 424B2 - BANK OF AMERICA CORP /DE/ <b>Filed:</b> 2026-08-17 <b>AccNo:</b> 0001918704-26-023932 <b>Size:</b> 1 MB

New Form 424B2 - BANK OF MONTREAL /CAN/ <b>Filed:</b> 2026-08-17 <b>AccNo:</b> 0001214659-26-010468 <b>Size:</b> 233 KB

New Form 424B2 - BANK OF MONTREAL /CAN/ <b>Filed:</b> 2026-08-17 <b>AccNo:</b> 0001214659-26-010467 <b>Size:</b> 265 KB

New Form 424B2 - BANK OF MONTREAL /CAN/ <b>Filed:</b> 2026-08-17 <b>AccNo:</b> 0001839882-26-040244 <b>Size:</b> 591 KB

Tanaka Kenji 🟡 adjusted position in 0 shares (2 derivative) of Sony Group Corp (SONY) at $8.41 Transaction Date: Aug 13, 2026 | Filing ID: 353728

Shareholder Alert: Ademi LLP investigates whether Fulcrum Therapeutics, Inc. is obtaining a Fair Price for Public Shareholders

New Form SCHEDULE 13D/A - Talkspace, Inc. <b>Filed:</b> 2026-08-17 <b>AccNo:</b> 0000950157-26-000917 <b>Size:</b> 13 KB

New Form 424B2 - UBS AG <b>Filed:</b> 2026-08-17 <b>AccNo:</b> 0001114446-26-005568 <b>Size:</b> 399 KB

New Form 424B2 - BANK OF MONTREAL /CAN/ <b>Filed:</b> 2026-08-17 <b>AccNo:</b> 0001839882-26-040243 <b>Size:</b> 403 KB

New Form 424B2 - UBS AG <b>Filed:</b> 2026-08-17 <b>AccNo:</b> 0001114446-26-005567 <b>Size:</b> 576 KB

New Form 8-A12B - AT&T INC. <b>Filed:</b> 2026-08-17 <b>AccNo:</b> 0001193125-26-354179 <b>Size:</b> 14 KB

New Form 424B2 - BANK OF MONTREAL /CAN/ <b>Filed:</b> 2026-08-17 <b>AccNo:</b> 0001214659-26-010466 <b>Size:</b> 223 KB

New Form 424B2 - UBS AG <b>Filed:</b> 2026-08-17 <b>AccNo:</b> 0001114446-26-005565 <b>Size:</b> 590 KB

New Form 424B2 - UBS AG <b>Filed:</b> 2026-08-17 <b>AccNo:</b> 0001114446-26-005563 <b>Size:</b> 407 KB

New Form 424B2 - UBS AG <b>Filed:</b> 2026-08-17 <b>AccNo:</b> 0001114446-26-005564 <b>Size:</b> 407 KB